| Wnt/beta-catenin pathway: modulating anticancer immune response SG Pai, BA Carneiro, JM Mota, R Costa, CA Leite, R Barroso-Sousa, ... Journal of hematology & oncology 10, 1-12, 2017 | 570 | 2017 |
| Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials R Costa, BA Carneiro, M Agulnik, AW Rademaker, SG Pai, VM Villaflor, ... Oncotarget 8 (5), 8910, 2017 | 134 | 2017 |
| FGFR3-TACC3 fusion in solid tumors: mini review R Costa, BA Carneiro, T Taxter, FA Tavora, A Kalyan, SA Pai, YK Chae, ... Oncotarget 7 (34), 55924, 2016 | 116 | 2016 |
| Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA YK Chae, AA Davis, BA Carneiro, S Chandra, N Mohindra, A Kalyan, ... Oncotarget 7 (40), 65364, 2016 | 113 | 2016 |
| Characterization of KRAS mutation subtypes in non–small cell lung cancer J Judd, N Abdel Karim, H Khan, AR Naqash, Y Baca, J Xiu, ... Molecular cancer therapeutics 20 (12), 2577-2584, 2021 | 89 | 2021 |
| Genomic characterization of high-risk non-muscle invasive bladder cancer JJ Meeks, BA Carneiro, SG Pai, DT Oberlin, A Rademaker, K Fedorchak, ... Oncotarget 7 (46), 75176, 2016 | 74 | 2016 |
| Therapies targeted to androgen receptor signaling axis in prostate cancer: progress, challenges, and hope S Saranyutanon, SK Srivastava, S Pai, S Singh, AP Singh Cancers 12 (1), 51, 2019 | 53 | 2019 |
| Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer SG Pai, BA Carneiro, YK Chae, RL Costa, A Kalyan, HA Shah, ... Journal of gastrointestinal oncology 8 (5), 858, 2017 | 45 | 2017 |
| Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives R Costa, BA Carneiro, S Chandra, SG Pai, YK Chae, JB Kaplan, ... Drug design, development and therapy, 873-884, 2016 | 44 | 2016 |
| Cellular and molecular progression of prostate cancer: models for basic and preclinical research S Saranyutanon, SK Deshmukh, S Dasgupta, S Pai, S Singh, AP Singh Cancers 12 (9), 2651, 2020 | 43 | 2020 |
| Angiotensin receptor blockers: are they related to lung cancer? GA Rao, JR Mann, A Shoaibi, SG Pai, M Bottai, SS Sutton, KS Haddock, ... Journal of Hypertension 31 (8), 1669-1675, 2013 | 43 | 2013 |
| Phase I study of the arginase inhibitor INCB001158 (1158) alone and in combination with pembrolizumab (PEM) in patients (Pts) with advanced/metastatic (adv/met) solid tumours A Naing, T Bauer, KP Papadopoulos, O Rahma, F Tsai, E Garralda, ... Annals of Oncology 30, v160, 2019 | 30 | 2019 |
| Novel therapeutic agents in the treatment of metastatic colorectal cancer SG Pai, J Fuloria World journal of gastrointestinal oncology 8 (1), 99, 2016 | 28 | 2016 |
| The challenge of developmental therapeutics for adrenocortical carcinoma R Costa, BA Carneiro, F Tavora, SG Pai, JB Kaplan, YK Chae, S Chandra, ... Oncotarget 7 (29), 46734, 2016 | 27 | 2016 |
| Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma GK Patel, JA Laurini, A Bhardwaj, K Roveda, R Donnell, K Sherling, ... Journal of Gastrointestinal Oncology 10 (4), 695, 2019 | 22 | 2019 |
| The association between EGFR and cMET expression and phosphorylation and its prognostic implication in patients with breast cancer YK Chae, DM Gagliato, SG Pai, B Carneiro, N Mohindra, FJ Giles, ... PLoS One 11 (4), e0152585, 2016 | 18 | 2016 |
| The effects of HER2 alterations in EGFR mutant non-small cell lung cancer M Nagasaka, V Singh, Y Baca, A Sukari, C Kim, H Mamdani, AI Spira, ... Clinical lung cancer 23 (1), 52-59, 2022 | 15 | 2022 |
| Thymineless death by the fluoropyrimidine polymer F10 involves replication fork collapse and is enhanced by Chk1 inhibition C Mani, S Pai, CM Papke, K Palle, WH Gmeiner Neoplasia 20 (12), 1236-1245, 2018 | 14 | 2018 |
| Ethics and medico legal aspects of “not for resuscitation” NS Salins, SG Pai, MS Vidyasagar, M Sobhana Indian journal of palliative care 16 (2), 66, 2010 | 14 | 2010 |
| The prevalence of DPYD* 9A (c. 85T> C) genotype and the genotype-phenotype correlation in patients with gastrointestinal malignancies treated with fluoropyrimidines: updated … AS Maharjan, GA McMillin, GK Patel, S Awan, WR Taylor, S Pai, ... Clinical colorectal cancer 18 (3), e280-e286, 2019 | 12 | 2019 |
Naveen SalinsKasturba Medical College ManipalVerified email at manipal.edu
